() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Neptune Technologies and Bioressources

Neptune Confirms its Name Change to Neptune Wellness Solutions Inc.

Sept. 19, 2018 /CNW Telbec/ - Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX: NEPT) announces that its shareholders have approved at the Annual Meeting of Shareholders held on August 15, 2018, the change of the Company's legal name to Neptune Wellness Solutions Inc / Neptune Solutions Bien-Être Inc., in order to better reflect the Company's products and business. The name change will be effective upon opening of the markets on September 21, 2018. The Company's common shares will keep trading under the same ticker symbol "NEPT" on NASDAQ and TSX.
Read more

Neptune Receives Confirmation of Readiness Letter from Health Canada

Sept. 17, 2018 /CNW Telbec/ - Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (NASDAQ – TSX: NEPT) today announced that it has received a Confirmation of Readiness letter from Health Canada in regard to its application to become a Licensed Producer under the ACMPR (Access to Cannabis for Medical Purposes Regulations).
Read more

Neptune Announces First Quarter Results

On a consolidated basis, until the loss of control on December 27, 2017, the first quarter ended June 30, 2017 includes a Non-IFRS operating loss1 of $2.1 million and a net loss of $2.8 million for Neptune's subsidiary, Acasti, which is actively engaged in clinical studies and research and development.   Cash and cash equivalents, including $2.4 million of restricted short-term investments, were $22.9 million as at June 30, 2018.
Read more